ESSEX INVESTMENT MANAGEMENT CO LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q1 2024. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
ESSEX INVESTMENT MANAGEMENT CO LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2024$57,663
-14.8%
697
-12.1%
0.01%
-15.4%
Q1 2024$67,683
-28.8%
793
-28.7%
0.01%
-31.6%
Q4 2023$95,087
-90.5%
1,112
-90.1%
0.02%
-88.4%
Q3 2023$1,004,013
+17.9%
11,208
+12.1%
0.16%
+37.8%
Q2 2023$851,40010,0000.12%
Other shareholders
HAEMONETICS CORP shareholders Q1 2024
NameSharesValueWeighting ↓
Black Creek Investment Management Inc. 1,014,941$33,077,0003.62%
Camber Capital Management LP 1,202,000$39,173,0003.07%
AMERICAN CAPITAL MANAGEMENT INC 718,380$23,412,0002.76%
Van Berkom & Associates Inc. 1,258,322$41,009,0002.31%
SNYDER CAPITAL MANAGEMENT L P 1,222,547$39,843,0002.07%
KESTREL INVESTMENT MANAGEMENT CORP 441,250$14,380,0001.78%
STONE RUN CAPITAL, LLC 33,740$1,100,0000.80%
HERMES INVESTMENT MANAGEMENT LTD 728,123$23,730,0000.75%
ANCHOR CAPITAL ADVISORS LLC 1,119,060$36,470,0000.73%
Netols Asset Management, Inc. 137,267$4,473,0000.72%
View complete list of HAEMONETICS CORP shareholders